Navigation Links
Life Sciences Discovery Fund makes company grants in health-related technologies
Date:7/24/2012

SEATTLE, Washington, July 23, 2012 The Life Sciences Discovery Fund (LSDF) today announced nearly $570,000 in awards in its inaugural corporate grant program to support commercialization of new health and health-care products by four early-stage Washington-based companies.

Three of the new "PreCede" grants focus on improving the management of serious medical conditions. Glenn Kawasaki of Carepeutics, Inc., will test a technology for predicting patient responses to anticancer drugs to inform treatment decisions. Tom Sanko of EchoGuide Medical, Inc. (formerly Harpoon Navigation, Inc.), will develop and test an ultrasound-guided system for placing catheters in the brain to drain excess cerebrospinal fluid. Robert Wilcox of Viket Medical Corporation will test a new approach for removing blood clots from the brains of individuals who have suffered a type of stroke called intracranial hemorrhage.

The fourth grant, to Thomas Schulte of Nexgenia, Inc., will optimize and scale up novel reagents to improve the speed and sensitivity of clinical assays for diagnosing various diseases.

The PreCede grant competition is designed to help position early-stage Washington life sciences companies for near-term equity investment. PreCede grants support research and development activities focused on validating the commercial merit of promising health-related technologies.

"LSDF has provided grant funding since 2007 to accelerate the movement of promising technologies into the commercial marketplace," stated LSDF Executive Director John DesRosier. "Today's grants represent LSDF's first dedicated mechanism to provide funding directly to companies. We have been encouraged and heartened by the strong support of and interest in this grant program from Washington's life sciences sector."

Washington Biotechnology & Biomedical Association President Chris Rivera noted that PreCede grants meet a vital need within the state's life sciences community, particularly in the current funding climate. "These grants support activities such as 'proof of concept' studies and prototype construction and testing that are critical for attracting angel and venture capital investment to complete development and successfully launch new products."

The PreCede awards were chosen from the eight proposals reviewed in the competition. National experts recruited by the American Association for the Advancement of Science evaluated the scientific and technical merit of the projects, and panels of commercialization and financial experts assessed each project's commercial potential and possible health and economic benefits. The LSDF Board of Trustees made the final award selections.

"A robust for-profit life sciences sector in Washington is critical for commercialization and market penetration of new products, which are in turn expected to lead to both health and economic benefits for our state," explained Lura Powell, chair of the LSDF Board of Trustees. "The board is pleased to use PreCede grant funding to both move new health-related products forward and foster the development of the state's for-profit life sciences community."

LSDF will continue to offer grant funding for both for-profit and non-profit Washington organizations, with granting programs to be announced in August 2012. Additional information will be posted on the LSDF website at http://www.lsdfa.org/ as it is available.

Funding for PreCede grant awards comes from Washington's allocation of payments under the Master Tobacco Settlement Agreement of 1998, revenues arising from multi-state litigation with tobacco product manufacturers.

The Life Sciences Discovery Fund, a Washington state agency established in May 2005, makes grant investments in innovative life sciences research to benefit Washington and its citizens.


'/>"/>
Contact: Cathyryne Manner
manner@lsdfa.org
206-456-9583
Life Sciences Discovery Fund
Source:Eurekalert

Related medicine news :

1. Lauren Sciences LLCs research team at Ben-Gurion University awarded Campbell Foundation grant to develop a V-Smart therapeutic for neuro-HIV
2. Natural Sciences Repository Publishes Chromatography and Acidic Compounds Resources
3. New Anthropology and Archaeology Resources Published at Sciences Social Network
4. Novel Natural Sciences Repository Opens Web Portal
5. UCSC physicist Alexander Sher named Pew Scholar in the Biomedical Sciences
6. UT MD Anderson President Ronald DePinho elected to National Academy of Sciences
7. Ivy Neurological Sciences Internship program funded at TGen
8. Hutchinson Center president elected to American Academy of Art and Sciences
9. Washingtons Life Sciences Discovery Fund awards commercialization grants
10. Evolutionary information improves discovery of mutations associated with diseases
11. Discovery improves understanding of early onset inflammatory disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... 2017 , ... The Wharton School of the University of Pennsylvania is pleased ... a $10 million gift to establish the Ken Moelis and Julie Taffet Moelis ... a Wharton MBA for highly-qualified Penn undergraduates whose academic and career interests expand traditional ...
(Date:3/29/2017)... , ... March 29, 2017 , ... VisualSP has helped ... Until recently, the only option for on-premises installation of its Help System for SharePoint ... to install the system into the entire tenant. , The company recently released ...
(Date:3/28/2017)... ... 28, 2017 , ... Tuesday, March 28, 2017, is the annual American Diabetes ... Risk Test to find out if they are at risk for developing Type 2 ... the evening sky by programming the LAX pylons the color red. Downtown’s U.S. Bank ...
(Date:3/28/2017)... ... March 28, 2017 , ... India’s Chigurupati Technologies announced ... address the resolution to globally reduce the harmful use of alcohol set forth ... and TTB approved ingredients that when infused into alcohol, renders the alcohol liver ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... is pleased to be invited to the Siemens Healthineers annual customer education symposium, ... The event will take place from March 27 - 31, 2017 at the ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 2017 Research and Markets has announced the ... report to their offering. ... The global energy-based aesthetic devices market to grow at ... The report, Global Energy-Based Aesthetic Devices Market 2017-2021, has been prepared ... The report covers the market landscape and its growth prospects over ...
(Date:3/29/2017)... , March 29, 2017  Novartis announced ... (FDA) has accepted the company,s Biologics License Application ... (tisagenlecleucel-T), an investigational chimeric antigen receptor T cell ... and young adult patients with B-cell acute lymphoblastic ... by Novartis for a CAR-T. The priority review ...
(Date:3/29/2017)...  The Global Health Innovative Technology Fund (GHIT ... battle infectious diseases around the globe, today announced ... help deliver a range of new innovative therapies ... This latest round of targeted support includes ... a pediatric formulation of a drug considered the ...
Breaking Medicine Technology: